S, P., ZA, W., CD, W., M, F., PM, K., CE, D., . . . EM, O. (2024). Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: The phase 1 AMPLIFY-201 trial. Nature medicine, 30(2), 531. https://doi.org/10.1038/s41591-023-02760-3
Chicago Style (17th ed.) CitationS, Pant, et al. "Lymph-node-targeted, MKRAS-specific Amphiphile Vaccine in Pancreatic and Colorectal Cancer: The Phase 1 AMPLIFY-201 Trial." Nature Medicine 30, no. 2 (2024): 531. https://doi.org/10.1038/s41591-023-02760-3.
MLA (9th ed.) CitationS, Pant, et al. "Lymph-node-targeted, MKRAS-specific Amphiphile Vaccine in Pancreatic and Colorectal Cancer: The Phase 1 AMPLIFY-201 Trial." Nature Medicine, vol. 30, no. 2, 2024, p. 531, https://doi.org/10.1038/s41591-023-02760-3.